Jason Slakter
2015
In 2015, Jason Slakter earned a total compensation of $610.6K as Chief Executive Officer at Ohr Pharmaceutical, a 1,488% increase compared to previous year.
Compensation breakdown
| Option Awards | $247,289 |
|---|---|
| Salary | $200,000 |
| Stock Awards | $163,333 |
| Total | $610,622 |
Slakter received $247.3K in option awards, accounting for 40% of the total pay in 2015.
Slakter also received $200K in salary and $163.3K in stock awards.
Rankings
In 2015, Jason Slakter's compensation ranked 10,073rd out of 13,638 executives tracked by ExecPay. In other words, Slakter earned more than 26.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,073 out of 13,638 | 26th |
Division Manufacturing | 3,847 out of 5,190 | 26th |
Major group Chemicals And Allied Products | 1,410 out of 1,854 | 24th |
Industry group Drugs | 1,156 out of 1,528 | 24th |
Industry Pharmaceutical Preparations | 905 out of 1,182 | 23rd |
Source: SEC filing on March 3, 2017.
Slakter's colleagues
We found two more compensation records of executives who worked with Jason Slakter at Ohr Pharmaceutical in 2015.